JPRN-jRCT1080220971未知4 期
Postmarketing clinical study on AO-128
适应症
试验速览
- 阶段
- 4 期
- 入组人数
- 197
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.The subject is an out patient during screening
- •2.The subject signs a written informed consent form prior to the initiation of any study procedures.
- •And the others.
排除标准
- •1.The subject with serious cardiac disease, cerebrovascular disorder, or any serious pancreatic or hematological disease, etc..
- •2.The subject who is considered ineligible to participate in the study by the investigator or subinvestigator.
- •And the others.
研究者
相似试验
已完成
4 期
Postmarketing Clinical Study on AO-128Impaired Glucose Tolerance (IGT)NCT02287402Takeda197
已完成
不适用
A post market clinical follow-up study with the Optimys Stem, with initial RSA analysisHip ArthroplastyHip replacement10023213NL-OMON47653Stichting SCORE150
已完成
不适用
A post market clinical follow-up study with the artificial hip joint CBH Stem, with initial RSA analysiship arthroplastyhip replacement10023213NL-OMON47657Xpert Orthopedie150
未知
4 期
Postmarketing clinical study on AG-1749-clinical study on non-erosive reflux diseaseon-erosive reflux diseaseJPRN-jRCT1080221028Takeda Pharmaceutical Company Limited
招募中
不适用
Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker FamilyBradyardiaslow heart rate10007521NL-OMON56135BIOTRONIK SE and Co.KG30